1. Natural Products
  2. Plants
  3. Compositae
  4. Erigeron breviscapus (Vant.) Hand.-Mazz.

Erigeron breviscapus (Vant.) Hand.-Mazz.

Erigeron breviscapus (Vant.) Hand.-Mazz. (13):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N0728
    α-Linolenic acid 463-40-1 99.56%
    α-Linolenic acid, isolated from Perilla frutescens, is an essential fatty acid that cannot be synthesized by humans. α-Linolenic acid can affect the process of thrombotic through the modulation of PI3K/Akt signaling. α-Linolenic acid possess the anti-arrhythmic properties and is related to cardiovascular disease and cancer.
    α-Linolenic acid
  • HY-N2085
    L-Perillaldehyde 18031-40-8
    L-Perillaldehyde is a major component in the essential oil containing in Perillae Herba. Inhalation of L-Perillaldehyde shows antidepressant-like activity through the olfactory nervous function.
  • HY-N0128
    Sclareol 515-03-7 ≥98.0%
    Sclareol is isolated from Salvia sclarea with anticarcinogenic activity. Sclareol shows strong cytotoxic activity against mouse leukemia (P-388), human epidermal carcinoma (KB) cells and human leukemia cell lines. Sclareol induces cell apoptosis.
  • HY-N0129
    Sclareolide 564-20-5 ≥98.0%
    Sclareolide is isolated from the flower of Perilla frutescens with antibacterial and cytotoxic activities.
  • HY-107802
    Breviscapine 116122-36-2
    Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris.
  • HY-N2629
    Erigoster B 849777-61-3
    Erigoster B is the active component of Erigeron breviscapus (Vant.) Hand.-Mazz. (an important Chinese herb), which has neuroprotective effects. Erigoster B can be used to prepare anti-nerve damage reagents to inhibit various nerve cell damage. It can also be used for cardio-cerebrovascular and tumor research.
    Erigoster B
  • HY-N3586
    Cimidahurinine 142542-89-0
    Cimidahurinine can be extracted from the seeds of Perilla frutescens.
  • HY-N0827
    Perillene 539-52-6
    Perillene is a component of the essential oil, has antibacterial and antitumor effects.
  • HY-N9508
    Perilla ketone 553-84-4 99.80%
    Perilla ketone is a naturally occurring xenobiotic compound. Perilla ketone is activated by pulmonary P450 cytochrome enzymes in the lung, resulting in severe pulmonary damage and development of diffuse pulmonary edema.
    Perilla ketone
  • HY-N4024
    Hyptadienic acid 128397-09-1
    Hyptadienic acid is a triterpene acid that can be isolated from the leaves of Perilla frutescens. Hyptadienic acid inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice with an ID50 value of 0.13 mg/ear. Hyptadienic acid can be used for the research of inflammation.
    Hyptadienic acid
  • HY-N8042
    Erigeside I 224824-74-2
    Erigeside I is a free radical scavenger isolated from Erigeron breviscapus.
    Erigeside I
  • HY-N12321
    2',3'-Dihydroxy-4',6'-dimethoxychalcone (compound 1) can inhibit Amyloid β-protein (Aβ42) fibrillization and aggregation. 2',3'-Dihydroxy-4',6'-dimethoxychalcone has oral activity and can be detected in the brain.
  • HY-N3094
    Periglaucine A 1025023-04-4
    Periglaucine A, a hasubanane-type alkaloid, can be isolated from Pericampylus glaucus. Periglaucine A can inhibits HBV surface antigen (HBsAg) secretion in Hep G2.2.15 cells. Periglaucine A also shows anti-HIV-1 activity in C8166 cells (EC50: 204 μM).
    Periglaucine A